ArticleNature cell biology2018
m
Open access · greenAbstract read
In one paragraph
Article in Nature cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 520 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
520citing papers in PubMed, 1 pooled it
41.4field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
520 citing papers in PubMed, 1 synthesis or guideline pooled it, 864 citations in OpenAlex.
- DNA methylation in monozygotic twins discordant for acute lymphoblastic leukemia: a case report and systematic review.Clinical epigenetics · 2025Pooled it
- Advanced deep learning strategies in nanopore RNA sequencing.RNA biology · 2026Review
- p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway.Oncogene · 2026Article
- Longer-lived mammals exhibit greater evolutionary conservatism and epigenetic modification at cancer-associated loci.Nature communications · 2026Article
- Emerging roles of mJournal of assisted reproduction and genetics · 2026Review
- Single-cell and spatial transcriptomic analysis reveal distinct tumor microenvironment signatures in primary and recurrent hypopharyngeal squamous cell carcinoma.Cellular & molecular biology letters · 2026Article
- YTHDF1 enhances ACSL3 translation in an m6A-dependent manner to regulate lipid metabolism and colorectal cancer progression.Translational cancer research · 2026Article
- Unravelling Multilayered RNA Modification Networks in Female Reproduction and Obstetric/Gynaecologic Disorders.Biomolecules · 2026Review
- Article
- WTAP stabilized by USP7 contributes to enzalutamide resistance in prostate cancer via mediating AKT mCancer gene therapy · 2026Article
- m6A RNA modification and its emerging roles in diseases: recent advances and therapeutic implications.Journal of translational medicine · 2026Review
- FTO promotes the cervical cancer progression via regulation of FGF2 expression.Annals of medicine and surgery (2012) · 2026Article
- NNature reviews. Cancer · 2026Review
- Advances in endometrial cancer screening: a comprehensive review of current methods and emerging technologies.International journal of clinical oncology · 2026Review
- m6A modification and its clinical applications in gynaecological cancer.Apoptosis : an international journal on programmed cell death · 2026Review
- Emerging roles of tRNA modification-mediated codon-specific translational reprogramming in cancer biology.Cell death & disease · 2026Review
- FTO-mediated m6A demethylation of CSF3 suppresses NETosis via downregulation of RLN2 expression in colorectal cancer.Cell biology and toxicology · 2026Article
- Identification and exploration of potential N6-methylation related mRNAs in endometriosis.Frontiers in genetics · 2026Article
- Tamoxifen differentially modulates endometrial hyperplasia via wild-type and mutant p53 regulation of the ALKBH5-REG1A axis.Frontiers in oncology · 2026Article
- Epitranscriptomic control of epithelial-mesenchymal transition in cancer: mechanisms, plasticity, and therapeutic opportunities.Frontiers in cell and developmental biology · 2026Review
460 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 4 institutions in 2 countries.
Jun Liu *Department of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.
Mark A Eckert *Department of Obstetrics and Gynecology/Section of Gynecologic Oncology, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-3166-3440
Bryan T Harada *Department of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-9683-782X
Song-Mei Liu *Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhike LuDepartment of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.
Kangkang YuDepartment of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.
Samantha M TiendaDepartment of Obstetrics and Gynecology/Section of Gynecologic Oncology, The University of Chicago, Chicago, IL, USA.
Agnieszka ChryplewiczDepartment of Obstetrics and Gynecology/Section of Gynecologic Oncology, The University of Chicago, Chicago, IL, USA.
Allen C ZhuDepartment of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.
Ying YangCenter for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jing-Tao HuangCenter for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China.
Shao-Min ChenCenter for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhi-Gao XuDepartment of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xiao-Hua LengHubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xue-Chen YuDepartment of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jie CaoMOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China.
Zezhou ZhangMOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China.
Jianzhao LiuMOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0001-9465-6075
Ernst LengyelDepartment of Obstetrics and Gynecology/Section of Gynecologic Oncology, The University of Chicago, Chicago, IL, USA. elengyel@uchicago.edu.ORCID http://orcid.org/0000-0001-8624-1507
Chuan HeDepartment of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA. chuanhe@uchicago.edu.ORCID http://orcid.org/0000-0003-4319-7424
Howard Hughes Medical Institute · USWuhan University · CNUniversity of Chicago · USZhejiang University · CN
Funding
VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1MTranscriptome-wide base-resolution sequencing of pseudouridine in human normal and AD brain tissues-CEGS Admin supplement 2020-2021RM1HG008935 · NHGRI · UNIVERSITY OF CHICAGO · PI HE, CHUAN · 2016 to 2025
$24.4MRegulation of Adhesion and Proteolysis in Ovarian CancerR01CA111882 · NCI · UNIVERSITY OF CHICAGO · PI LENGYEL, ERNST · 2006 to 2016
$2.8MBase-resolution sequencing of m6A in RNAR01HG008688 · NHGRI · UNIVERSITY OF CHICAGO · PI HE, CHUAN · 2015 to 2017
$1.3MThe Effects of ERK2-Induced Phosphorylation of METTL3 on N6-methyladenosine (m6A) mRNA Methylation in MelanomaF30CA247175 · NCI · UNIVERSITY OF CHICAGO · PI ZHU, ALLEN C · 2020 to 2023
$192kThe role of mRNA methylation in the progression of endometrial cancerF32CA221007 · NCI · UNIVERSITY OF CHICAGO · PI HARADA, BRYAN TSUTOMU · 2017 to 2019
$179kNCI NIH HHS F30 CA247175NCI NIH HHS F32 CA221007NCI NIH HHS P30 CA014599NCI NIH HHS R01 CA111882NHGRI NIH HHS R01 HG008688NHGRI NIH HHS RM1 HG008935
Abstract
N
Indexed as
CarcinogenesisCell ProliferationRNA Processing, Post-TranscriptionalAdenosineAnimalsCell Line, TumorEndometrial NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansMechanistic Target of Rapamycin Complex 2MethylationMethyltransferasesMice, NudeMutationPhosphoprotein PhosphatasesAdenosineMechanistic Target of Rapamycin Complex 2MethyltransferasesMETTL14 protein, humanMETTL3 protein, humanN-methyladenosinePHLPP2 protein, humanPhosphoprotein PhosphatasesProto-Oncogene Proteins c-aktRNA, MessengerRNA, Neoplasm
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.